Related Experiment Video
Updated: Jun 17, 2026
08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
The case for chemotherapy only for localized Hodgkin lymphoma
1Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. strausd@mskcc.org
The Oncologist
|December 17, 2009
Summary
Treatments for early-stage Hodgkin lymphoma, including radiation therapy (RT) and chemotherapy, cause significant late toxicities. Current research focuses on reducing RT doses, chemotherapy toxicity, and exploring chemotherapy-only options for improved patient outcomes.
Area of Science:
- Oncology
- Radiotherapy
- Pharmacology
Background:
- Radiation therapy (RT) and chemotherapy have been standard treatments for early-stage Hodgkin lymphoma for over 40 years.
- Significant late toxicities and mortality associated with these treatments are increasingly recognized.
- This necessitates a re-evaluation of current treatment paradigms.
Purpose of the Study:
- To review the late side effects of Hodgkin lymphoma treatment.
- To summarize results from trials using chemotherapy alone.
- To discuss strategies for reducing treatment toxicity and the role of positron emission tomography (PET) in treatment planning.
Main Methods:
- Literature review of studies on Hodgkin lymphoma treatment.
- Analysis of clinical trial data for chemotherapy-only approaches.
- Evaluation of strategies to mitigate treatment-related toxicities.
Main Results:
- Accumulating data highlight significant long-term adverse effects of combined RT and chemotherapy.
- Chemotherapy-alone strategies show promise in reducing late toxicities.
- Positron emission tomography (PET) is emerging as a valuable tool for personalized treatment planning.
Conclusions:
- Reducing RT doses and chemotherapy toxicity is crucial for improving long-term outcomes in early-stage Hodgkin lymphoma.
- Chemotherapy-only regimens may offer a viable alternative to minimize late adverse effects.
- Integrating PET imaging can optimize treatment strategies and reduce unnecessary interventions.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...